1.
Am J Hematol
; 99(3): 497-501, 2024 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38264797
RESUMO
Distinct outcomes of BRAF inhibition in BRAF-mutated hairy cell neoplasms with wild-type or mutant TP53, and alternative strategies to overcome mutant TP53.